BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
Saved in:
| Title: | BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer. |
|---|---|
| Authors: | Kwon MJ; College of Pharmacy, Kyungpook National University, Daegu, Korea.; Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea., Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Han J; Gencurix, Inc., Seoul, Korea., Lee JE; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Gong G; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Beitsch PD; Targeted Medical Education, Allentown, Pennsylvania, United States of America., Nam SJ; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ahn SH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Nam BH; HERINGS, The Institute of Advanced Clinical and Biomedical Research, Seoul, Korea., Shin YK; Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy, Seoul National University, Seoul, Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea. |
| Source: | PloS one [PLoS One] 2018 Nov 21; Vol. 13 (11), pp. e0207155. Date of Electronic Publication: 2018 Nov 21 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Validation Study |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30462685 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kwon+MJ%22">Kwon MJ</searchLink>; College of Pharmacy, Kyungpook National University, Daegu, Korea.; Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SB%22">Lee SB</searchLink>; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Han+J%22">Han J</searchLink>; Gencurix, Inc., Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JE%22">Lee JE</searchLink>; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JW%22">Lee JW</searchLink>; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Gong+G%22">Gong G</searchLink>; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Beitsch+PD%22">Beitsch PD</searchLink>; Targeted Medical Education, Allentown, Pennsylvania, United States of America.<br /><searchLink fieldCode="AU" term="%22Nam+SJ%22">Nam SJ</searchLink>; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+SH%22">Ahn SH</searchLink>; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Nam+BH%22">Nam BH</searchLink>; HERINGS, The Institute of Advanced Clinical and Biomedical Research, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Shin+YK%22">Shin YK</searchLink>; Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy, Seoul National University, Seoul, Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2018 Nov 21; Vol. 13 (11), pp. e0207155. <i>Date of Electronic Publication: </i>2018 Nov 21 (<i>Print Publication: </i>2018). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Validation Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30462685 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0207155 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0207155 Titles: – TitleFull: BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kwon MJ – PersonEntity: Name: NameFull: Lee SB – PersonEntity: Name: NameFull: Han J – PersonEntity: Name: NameFull: Lee JE – PersonEntity: Name: NameFull: Lee JW – PersonEntity: Name: NameFull: Gong G – PersonEntity: Name: NameFull: Beitsch PD – PersonEntity: Name: NameFull: Nam SJ – PersonEntity: Name: NameFull: Ahn SH – PersonEntity: Name: NameFull: Nam BH – PersonEntity: Name: NameFull: Shin YK IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 11 Text: 2018 Nov 21 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 13 – Type: issue Value: 11 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |